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 Lymphoedema is the build-up of lymphatic ﬂ uid leading to 
swelling in the tissues. Most commonly it affects the peripher-
ies. Diagnosis is based on clinical assessment and imaging 
with lymphoscintigraphy. Treatment is supportive with com-
pression garments, massage, good skin hygiene and prompt 
use of antibiotics to avoid the complication of cellulitis. Most 
commonly, lymphoedema occurs as a result of damage to 
the lymphatic system following surgery, trauma, radiation or 
infection. However, it can be primary, often associated with a 
genetic defect that causes disruption to the development of 
the lymphatic system. Common genetic conditions associated 
with lymphoedema include Turner syndrome and Noonan 
syndrome; however, there are numerous others that can be 
classiﬁ ed based on their clinical presentation and associated 
features. Herein we discuss how to diagnose and classify the 
known primary lymphoedema conditions and how best to 
investigate and manage this group of patients. 
 Introduction 
 The lymphatic system is a network of connected vessels, 
nodes and tissues, whose main function is in the body’s 
defence against infection. It also returns excess fluid from the 
tissues and fatty acids from the bowel to the bloodstream. 1 
Disruption of the normal flow of the lymphatic system leads to 
swelling (oedema). Most commonly, lymphoedema occurs as 
a result of damage to the lymphatic system following surgery, 
trauma, radiation or infection. However, it can be primary, 
associated with a disruption to the development or the 
function of the lymphatic system causing impaired drainage 
of lymph. This group of conditions will be the focus of the 
current review. 
 Clinical presentation 
 The presentation is most commonly associated with swelling 
in the extremities; however, it may involve any body site (eg 
facial or genital oedema). In addition, there may be systemic 
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(or visceral) involvement with chylothoraces, pericardial 
effusions, chylous reflux or intestinal lymphangiectasia 
(Fig  1 ). In primary lymphoedema, the underlying abnormality 
is usually present at birth but the swelling, although often 
congenital, may not develop until puberty or adulthood. Lower 
limb lymphoedema can be confirmed by a positive Stemmer’s 
sign, which is a thickened cutaneous fold of the second toe or 
second finger that can be gently pinched and lifted. 2 There 
may also be skin changes, such as papillomatosis (Fig  1 b), 
lymphangiectasia or lymphorrhoea in chronic lymphoedema 
and deep interphalangeal creases and nail changes with small, 
dysplastic, ‘ski-jump’ nails (Fig  1 a and  1 b). 
 Genetic basis of primary lymphoedema 
 For many years it was known that there were some families 
where there was likely inherited lymphoedema with or without 
additional features. However, it was not until 2000 that the 
gene for Milroy syndrome,  FLT4 ( VEGFR3 ), was discovered. 3,4 
Following this, numerous other genes that are associated with 
lymphatic disease have been discovered. Connell  et al detailed 
a classification system and diagnostic algorithm based on onset 
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and site of lymphoedema and associated features. 5 There are 
five main subgroups: 
 1  syndromic 
 2  lymphoedema with systemic/visceral involvement 
 3  overgrowth/vascular malformation syndromes 
 4  congenital onset (<1 year) 
 5  later onset (>1 year). 
 Since then, two new genes –  PIEZO1 and  EPHB4 – have been 
identified as a cause of generalised lymphatic dysplasia 6,7 and 
the overgrowth/vascular malformation syndromes are now 
collectively known as the  PIK3CA -related overgrowth spectrum 
(PROS) disorders because they are caused by somatic mutations 
in the phosphatidylinositol-3-kinase (PI3K)/AKT/mTOR 
pathway. 8 An adapted classification system is presented in Fig  2 . 
A summary of the features and presentations of some of the 
conditions can be found in Table  1 . 
 Syndromes associated with lymphoedema 
 Turner syndrome 
 Turner syndrome is a genetic condition affecting females who 
have only one normal X chromosome. Common features 
include antenatal hydrops or cystic hygroma, short stature, 
mild learning difficulties, congenital heart disease (commonly 
coarctation of the aorta), congenital renal anomalies, 
lymphoedema and infertility. Examination may identify low 
LDS Milroy
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 Fig 1.  Images demonstrating different types of primary lymphoedema, lymphoscintigraphy and possible complications . (a) Bilateral pedal oedema, 
deep interphalangeal creases and small, dysplastic, ‘ski-jump’ toenails in an individual with Milroy disease; (b) longstanding pedal oedema with papillomatosis in 
a female with Turner syndrome; (c) lymphoscintigraphy after 2 hours in a normal control, an individual with lymphoedema-distichiasis syndrome demonstrating 
lymphatic reﬂ ux, and an individual with Milroy disease showing paucity of lymphatic vessels; (d) generalised lymphoedema affecting the face, hands and feet in 
a patient with Hennekam syndrome ( CCBE1 ); (e) facial oedema in a patient with  PIEZO1 related-lymphoedema; (f) a chest radiograph demonstrating bilateral 
chylothoraces in a patient with Noonan syndrome . 
posterior hairline with webbed neck, widely spaced nipples 
and increased carrying angle. Lymphoedema typically presents 
at birth with four-limb lymphoedema, which often resolves, 
but may recur later in life. Lymphoscintigraphy suggests that 
the lymphatic phenotype of Turner syndrome may be due to a 
failure of initial lymphatic (capillary) function. 9 
 Noonan syndrome 
 Noonan syndrome is a relatively common condition that 
follows an autosomal dominant pattern of inheritance. It 
is associated with alterations in genes encoding the Ras/
MAPK pathway. Common features include antenatal hydrops 
or cystic hygroma, short stature, mild learning difficulties, 
congenital heart disease (commonly pulmonary stenosis 
or hypertrophic cardiomyopathy), cryptorchidism, hernias 
and bleeding diathesis. Examination may identify distinct 
facial features (down slanting palpebral fissures, ptosis, low 
set posteriorly rotated ears) and webbed neck. Congenital 
lymphoedema is fairly common in this disorder, but a few 
patients may develop lymphoedema in childhood, with a 
characteristic pattern of bilateral lower limb lymphoedema, 
genital swelling with chylous reflux and frequent systemic 
involvement, including intestinal lymphangiectasia 
and chylothoraces (Fig  1 e), which may be progressive. 
Lymphoscintigraphy demonstrates reflux and/or rerouting of 
lymphatic drainage associated with incompetent veins on the 
venous duplex scans. 10 
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 Generalised lymphatic dysplasia 
 Hennekam syndrome 
 Hennekam syndrome is a rare condition with an autosomal 
recessive pattern of inheritance associated with alterations 
in the  CCBE1 and  FAT4 genes, 11,12 which account for 
approximately 50% of cases. Presentation is usually with 
congenital or antenatal onset (hydrops) of generalised severe 
lymphoedema, lymphangiectasia, learning difficulties, seizures, 
microcephaly, short stature and characteristic facial features 
(puffy eyelids, flattened facial profile, hypertelorism, gingival 
hypertrophy and microstomia) (Fig  1 d). 
 PIEZO1-related lymphatic-related hydrops/generalised 
lymphatic dysplasia 
 This is a newly described condition following autosomal 
recessive inheritance related to alterations in the  PIEZO1 
gene. 6 It is characterised by a uniform, widespread 
lymphoedema affecting all segments of the body, with 
systemic involvement – such as pulmonary lymphangiectasia, 
pleural effusions, chylothoraces and/or pericardial effusions 
(Fig  1 e). Presentation may be with non-immune hydrops. In 
comparison to Hennekam syndrome, intelligence is normal, 
with no seizures or distinct facial features other than swelling. 
 EPHB4-related lymphatic-related hydrops 
 In 2016, Martin-Almedina  et al reported two unrelated 
autosomal dominant families with  in utero hydrops/neonatal 
deaths found to be due to heterozygous missense mutations in 
 EPHB4 on exome sequencing. 7 There was a high incidence of 
atrial septal defects in these families.  EPHB4 was found to be an 
important regulator of early lymphatic vascular development 
and mutations in the gene can cause an autosomal dominant 
form of non-immune hydrops with variable expressivity, but 
associated with high mortality rate. 
 Lymphoedema associated with overgrowth 
and/or vascular malformations 
 PIK3CA-related overgrowth spectrum 
 In 2015, Keppler-Noreuil  et al delineated PROS, a 
heterogeneous group of disorders associated with somatic 
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 Fig 2.  Classiﬁ cation criteria for diagnosis of primary lymphoedema. Genes are marked in italics. Adapted from Connell  et al . 5 CLOVE =  congenital lipo-
matous overgrowth, vascular malformations, and epidermal nevi; FH = ﬁ broadipose hyperplasia; KT = klippel-trenaunay; KTS = klippel-trenaunay syndrome; 
WILD = warts, immunodeﬁ ciency, lymphoedema, dysplasia 
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 Congenital lymphoedema 
 Milroy disease 
 Milroy disease is a condition that follows an autosomal 
dominant pattern of inheritance, characterised by antenatal or 
congenital onset of bilateral lower limb lymphoedema. Large 
calibre veins and upslanting ‘ski-jump’ toenails are commonly 
seen (Fig  1 a). Lymphoscintigraphy identifies functional 
aplasia, either due to paucity of the lymphatic vessels or 
abnormal function of the vessels in the lower limbs (Fig  1 c). 13 
Alterations in the  FLT4 ( VEGFR3 ) gene are causative. 3,4 In 
2013, Gordon  et al ascertained that mutations in  VEGFC , 
activating mutations in the PI3K/AKT/mTOR pathway. 8 
This group encompasses many conditions that were 
previously thought to be distinct (proteus, congenital 
lipomatous overgrowth, vascular malformations, epidermal 
nevi, scoliosis/skeletal and spinal (CLOVES) syndrome, 
macrodactyly and the related megalencephaly syndromes, 
including megalencephaly-capillary malformation [MCAP or 
M-CM]). However, it is now known that there is significant 
overlap in the clinical features, which include overgrowth 
(adipose, muscle, nerve, skeletal), vascular malformations 
(capillary, venous, arteriovenous malformation, lymphatic) 
and epidermal naevi. 
 Table 1.  Primary lymphoedema conditions, including genetic basis and inheritance, onset and nature of 
lymphoedema and associated features 
Condition Genetic basis Inheritance Onset and nature of 
lymphedema 
Associated features 
Turner syndrome 45,X (or similar) Sporadic Congenital (may be 
prenatal), hands and feet
Short stature, webbed neck, widely 
spaced nipples and increased carrying 
angle, CHD (coarctation of aorta), 
renal anomalies, primary infertility, 
mild intellectual disability
Noonan syndrome >23 rasopathy 
genes including: 
 PTPN11, SOS1, 
RAF1, RIT1, KRAS, 
NRAS, BRAF, 
MAP2K1 
AD Congenital (may be 
prenatal), lower limb Later 
onset genital oedema, 
chylous reflux, intestinal 
lymphangiectasia, and/or 
chylothoraces
Short stature, webbed neck, CHD 
(pulmonary stenosis or hypertrophic 
cardiomyopathy), dysmorphic features, 
bleeding tendency, intellectual 
disability, cryptorchid testes, pectus 
deformities
Hennekam syndrome  CCBE1 AR Congenital, multi-
segment, facial, 
lymphangiectasia
Microcephaly, distinct facial features, 
intellectual disability, short stature, 
respiratory problems, skeletal anomalies, 
anaemia, polysplenia, renal anomalies. 
Systemic lymphatic involvement
 PIEZO1 -related lymphatic-
related hydrops/generalised 
lymphatic dysplasia
 PIEZO1 AR Non-immune hydrops, 
childhood onset 
multisegment
Systemic involvement (chylothoraces 
and/or pericardial effusions)
 EPHB4 -related lymphatic-
related hydrops
 EPHB4 AD Non-immune hydrops Atrial septal defects
 PIK3CA- related overgrowth 
spectrum (PROS)
PI3K/AKT/mTOR 
pathway
Somatic Congenital Hypertrophy/overgrowth of bone and 
soft tissues resulting in asymmetry, 
vascular malformations, naevi/
pigmentation
Milroy syndrome  VEGFR3, VEGFC AD Congenital, pedal, lower 
limb
Hydrocele, prominent veins, upslanting 
toenails, papillomatosis, and urethral 
abnormalities in males
Microcephaly-chorioretinopathy-
lymphedema-mental retardation 
(MCLMR)
 KIF11 AD Congenital, lower limb Microcephaly, chorioretinopathy, 
intellectual disability, epilepsy, CHD
Lymphedema distichiasis  FOXC2 AD Pubertal, lower limb Distichiasis, varicose veins, ptosis, cleft 
palate, CHD, renal anomalies
Emberger syndrome  GATA2 AD Childhood, lower limb 
and/or genital
Myelodysplasia, sensorineural hearing 
loss
Primary lymphedema GJC2 AD Childhood/adolescence or 
postnatal, four limb
 Genes written in italics. AD = autosomal dominant; AR = autosomal recessive; CHD = congenital heart disease. 
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which is a ligand for  VEGFR3, are responsible for Milroy-like 
lymphoedema. 14 
 Microcephaly-chorioretinopathy-lymphoedema-mental 
retardation 
 Microcephaly-chorioretinopathy-lymphoedema-mental 
retardation is associated with alterations in the  KIF11 gene 15 
and follows an autosomal dominant pattern of inheritance. It 
is included in this section as there is a very high incidence of 
congenital lower limb lymphoedema (46%). It is characterised 
by primary microcephaly, chorioretinal dysplasia, typically 
congenital bilateral pedal lymphoedema and mild to moderate 
learning difficulties. Epilepsy and congenital heart disease 
may also be associated. There is significant variability in 
presentation and reduced penetrance has been reported. 16 
 Late onset lymphoedema 
 Lymphoedema-distichiasis syndrome 
 This condition follows an autosomal dominant pattern of 
inheritance and is characterised by lower-limb lymphoedema, 
usually of pubertal onset, and distichiasis (aberrant extra 
eyelashes originating from the meibomian glands). This may be 
a whole additional row of eyelashes or a single hair. Distichiasis 
may lead to corneal irritation, recurrent conjunctivitis and 
photophobia. Other commonly associated features include 
ptosis, congenital heart disease and cleft palate. 17 FOXC2 is 
the only gene, to date, in which mutations are known to cause 
lymphoedema-distichiasis syndrome. 18 The lymphatic and 
venous valves in this condition are dysplastic and leaky so there 
is a high incidence of varicose veins and lymphoscintigraphy 
shows dermal backflow, suggestive of lymph reflux into the 
lower limbs (Fig  1 c). 
 Emberger syndrome 
 Emberger syndrome is characterised by the combination 
of lymphoedema and predisposition to development of 
myelodysplasia and acute myeloid leukaemia with autosomal 
dominant inheritance. It is caused by alterations in the 
 GATA2 gene. 19 Presentation is typically with childhood onset 
(although may be prenatal or congenital), bilateral, pedal +/− 
genital oedema, which usually predates the haematological 
abnormalities. There may be immune dysfunction and 
myelodysplasia (karyotypic anomalies include monosomy 7), 
which may progress to acute myeloid leukaemia. 
 GJC2-related lymphoedema 
 In 2010, alterations in the  GJC2 gene were identified as a 
cause of autosomal dominant lymphoedema. 20 Ostergaard 
 et al further characterised the features of this condition, 
which presents in the first or second decade with four-limb 
lymphoedema and increased incidence of varicose veins. 21 
 Meige syndrome 
 This condition presents with lower limb lymphoedema in 
adolescence or adulthood. There are a number of families 
suggestive of autosomal dominant inheritance. There 
are usually no associated features. It is probably the most 
common form of primary lymphoedema. Lymphoscintigraphy 
demonstrates poor uptake at 2 hours and rerouting through the 
deep lymphatics, with the presence of popliteal lymph nodes 
(which are not usually visualised). No specific genes have been 
found for this condition. 
 There are numerous other conditions in which lymphoedema 
is a reported feature. These may have a chromosomal or single 
gene cause; however, in some the cause is unknown. A detailed 
list of these conditions can be found in Connell  et al . 5 
 Investigations and management 
 Following a detailed family history and examination, 
investigation of lymphoedema includes lymphoscintigraphy 
examination. This is the imaging of the lymphatic system by 
injecting a radioactive isotope into the web spaces between the 
toes (or fingers) and quantification of uptake into the inguinal 
(or axillary) lymph nodes after 2 hours (Fig  1 c). Decreased 
uptake suggests abnormal lymphatic drainage. If a specific 
genetic diagnosis is suspected, genetic testing can be arranged. 
This includes chromosomal analysis, or karyotype (for Turner 
syndrome), single gene or gene panel testing (if available). 
These tests can be performed on a peripheral blood sample; 
however, if PROS is suspected, a skin biopsy should be taken 
from an affected area and sent for genetic testing. 22 In view of 
the somatic nature of this condition, testing of blood may not 
yield the diagnosis. 
 In the main, treatment of lymphoedema is supportive. It 
includes manual lymphatic drainage and compression hosiery/
garments along with skin hygiene advice and appropriate 
footwear to reduce the risk of complications. Surgical treatment 
is largely unsuccessful and is not generally recommended. 
There are currently no effective drug therapies available for the 
management of primary lymphoedema. However, the use of 
drugs targeting the PI3K/AKT/mTOR signalling pathway, such 
as mTOR inhibitors, provides an exciting prospect for patients 
with PROS. 23 ■
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